Beauty Health (SKIN) Stock Overview
Designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for SKIN from our risk checks.
SKIN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Beauty Health Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.43 |
| 52 Week High | US$2.69 |
| 52 Week Low | US$0.78 |
| Beta | 1.22 |
| 1 Month Change | -40.17% |
| 3 Month Change | -10.06% |
| 1 Year Change | -10.63% |
| 3 Year Change | -87.79% |
| 5 Year Change | n/a |
| Change since IPO | -86.81% |
Recent News & Updates
The Market Doesn't Like What It Sees From The Beauty Health Company's (NASDAQ:SKIN) Revenues Yet As Shares Tumble 40%
Oct 14
The Beauty Health Company's (NASDAQ:SKIN) 30% Price Boost Is Out Of Tune With Revenues
Aug 30Recent updates
The Market Doesn't Like What It Sees From The Beauty Health Company's (NASDAQ:SKIN) Revenues Yet As Shares Tumble 40%
Oct 14The Beauty Health Company's (NASDAQ:SKIN) 30% Price Boost Is Out Of Tune With Revenues
Aug 30Analysts Are Updating Their The Beauty Health Company (NASDAQ:SKIN) Estimates After Its First-Quarter Results
May 11The Beauty Health Company (NASDAQ:SKIN) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 11
Sales Execution And Hydralock Booster Launch Will Strengthen Future Prospects
Operational improvements and strategic market positioning are set to enhance profitability and boost revenue growth.The Beauty Health Company (NASDAQ:SKIN) Analysts Just Cut Their EPS Forecasts Substantially
Mar 14Is Beauty Health (NASDAQ:SKIN) Weighed On By Its Debt Load?
Feb 27The Beauty Health Company (NASDAQ:SKIN) Doing What It Can To Lift Shares
Dec 27Health Check: How Prudently Does Beauty Health (NASDAQ:SKIN) Use Debt?
Oct 18Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump
Aug 06Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?
Jul 16Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%
Jun 14Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)
May 30The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company
Feb 16The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion
Jun 19Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?
May 28At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?
Apr 04Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality
Mar 08Shareholder Returns
| SKIN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -0.7% | -6.4% | -1.5% |
| 1Y | -10.6% | -17.9% | 14.4% |
Price Volatility
| SKIN volatility | |
|---|---|
| SKIN Average Weekly Movement | 12.9% |
| Personal Products Industry Average Movement | 8.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 3.0% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 769 | Pedro Malha | www.beautyhealth.com |
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health.
The Beauty Health Company Fundamentals Summary
| SKIN fundamental statistics | |
|---|---|
| Market cap | US$182.63m |
| Earnings (TTM) | -US$19.00m |
| Revenue (TTM) | US$310.06m |
Is SKIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKIN income statement (TTM) | |
|---|---|
| Revenue | US$310.06m |
| Cost of Revenue | US$119.38m |
| Gross Profit | US$190.69m |
| Other Expenses | US$209.69m |
| Earnings | -US$19.00m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 61.50% |
| Net Profit Margin | -6.13% |
| Debt/Equity Ratio | 490.7% |
How did SKIN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/17 01:15 |
| End of Day Share Price | 2025/10/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Beauty Health Company is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bruce Jackson | Benchmark Company |
| Navann Ty Dietschi | BNP Paribas Exane |
| Kyle Rose | Canaccord Genuity |